Skip to content
Politically.com Search all
Menu

2025 · 1st Quarter (Jan 1 - Mar 31)

TEXAS NEUROFIBROMATOSIS FOUNDATION

Filed by VAN SCOYOC ASSOCIATES.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-08-03 06:26:15 UTC.

Source-reported fields

Filing overview

Type
1st Quarter - Report
Posted
Apr 18, 2025
Income
Not reported
Expenses
Not reported
Filing UUID
c6e9dd26-2ea6-4d8e-b5f1-913f83b283df
Termination date
Not reported

Literal source text

Lobbying issues and bill citations

BUD · Budget/Appropriations

Medical research issues and Neurofibromatosis provisions, as follows: Public Law 119-4, Full-Year Continuing Appropriations and Extensions Act, FY2025 H.R.8774/S.4921, Department of Defense Appropriations Act, FY2025 Department of Defense Appropriations Act, FY2026 H.R.9029/S.4942, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2025 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2026

Literal federal measure citations: H.R.8774, S.4921, H.R.9029, S.4942

DEF · Defense

Medical research issues and Neurofibromatosis provisions, as follows: Public Law 119-4, Full-Year Continuing Appropriations and Extensions Act, FY2025 H.R.8774/S.4921, Department of Defense Appropriations Act, FY2025 Department of Defense Appropriations Act, FY2026

Literal federal measure citations: H.R.8774, S.4921

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.